Anita Brikman: Expanding Access to Plasma-Derived Medicines in India
Anita Brikman, President and CEO of the Plasma Protein Therapeutics Association (PPTA), shared on LinkedIn:
”Returning from India on behalf of Plasma Protein Therapeutics Association (PPTA), I look back at an incredibly meaningful- even transformative- journey.
Our time there was centered on listening, learning and strengthening partnerships across a rapidly evolving healthcare ecosystem.
From conversations with regulators and public health leaders to time spent with clinicians, patient advocates, and scientists, it’s clear that progress in expanding access to plasma-derived medicines could be deeply impactful.
I was especially moved by the dedication of individuals who have turned personal experience into advocacy.
Their efforts are helping to build momentum toward a future where more patients with rare and chronic conditions can receive timely and effective treatment with plasma-derived medicines.
While there is still much to be done, the growing collaboration across India signals real opportunity in expanding access to care across the region.
Thank you to the many partners who welcomed us, shared their insights, and continue to push this work forward.
It’s an honor to be part of the life-enabling power of plasma.”
Stay updated with Hemostasis Today.
-
Sep 17, 2026, 20:38Konstantinos Bistas: Reduced Circulating Tregs in Pediatric Chronic Neutropenia
-
Sep 17, 2026, 15:33Gopal Patidar: Honoured to Contribute to the ASFA 2026 Guidelines for Therapeutic Apheresis
-
Sep 17, 2026, 20:36Cosima C. Hoch: Developing a 3D Organotypic Co-Culture Model for Pleomorphic Adenoma
-
Sep 17, 2026, 20:19Riten Kumar: Boston Children’s Hospital Ranked No. 1 in Seven Pediatric Specialties
-
Sep 17, 2026, 20:17Katrina Snow: Whole Blood or Component Therapy – Which Would You Choose?
-
Sep 17, 2026, 16:30Daria Camilli: Empowering Bleeding Disorder Advocacy Through Health Economics
-
Sep 17, 2026, 16:17Mehran Ghasemzadeh: Platelet NK Cell Crosstalk in Advanced Coronary Artery Disease
-
Sep 17, 2026, 16:16Barbara Adams Krolak: Do GLP-1s Affect Blood Clot Risk?
-
Sep 17, 2026, 15:46Heghine Khachatryan: Clinical Context at the Core of Thrombosis and Thrombophilia Management